MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/21.03.25 Share Price

Warrant

DE000MB5C4N5

Market Closed - Börse Stuttgart 12:12:52 15/06/2024 am IST
0.149 EUR +1.36% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/21.03.25
Current month-22.80%
1 month-9.70%
Date Price Change
14/24/14 0.149 +1.36%
13/24/13 0.147 +6.52%
12/24/12 0.138 0.00%
11/24/11 0.138 -0.72%
10/24/10 0.139 -6.08%

Delayed Quote Börse Stuttgart

Last update June 15, 2024 at 12:12 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB5C4N
ISINDE000MB5C4N5
Date issued 05/04/2023
Strike 100 $
Maturity 21/03/2025 (278 Days)
Parity 10 : 1
Emission price 1.02
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.98
Lowest since issue 0.115
Spread 0.004
Spread %2.63%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus